Fellow

Back to directory listing

Professor David Klenerman FRS FMedSci

Job Title
Professor of Biophysical Chemistry
Department

Institution
University of Cambridge
Year elected
2015

Interests

Specialities

Single molecule biophysical methods applied to immunology and neurodegenerative disease.

Section committee elected by

Physics, chemistry, biochemistry, structural biology, mathematics, informatics and engineering applied to biomedicine

David Klenerman is Professor of Biophysical Chemistry at the University of Cambridge. His innovative development and insightful application of novel physical methods to biology and biomedicine has had a major impact on medical science. He co-invented the development of next generation DNA sequencing methods, which is one of the most important advances in biomedicine in the last decade. This invention was developed and commercialised by the spin out company Solexa, which he co-founded, and more than 1000 instruments have now been sold world-wide, making it the most widely used next generation method and used in most major sequencing centres in the world.

Related Items

Government support for research and innovation

Read more

Thought-leadership event on ‘The 21st century landscape for life sciences: the role of the NHS’

Read more

Professor Péter Somogyi FRS FMedSci jointly awarded Grete Lundbeck European Brain Research Prize

Read more

President provides evidence to Lords Committee regarding Government science strategy

Read more

Anniversary Fellows Meeting 2018

Book Now

Joint symposium on mental health and addiction: A discussion, exchange and sharing of perspectives

Book Now

South-East Regional Annual Lecture 2018, Oxford, 3 December

Book Now
View more
 
 
 
 
 
 
FB Twitter Instagram Youtube